Revvity earnings were $253.2M for the trailing 12 months ending Oct 4, 2026, with 13.1% growth year over year. The latest RVTY earnings report on Oct 4, 2026 announced Q4 2026 earnings of $62.3M, up 20.2% from last quarter. For the last reported fiscal year 2025 ending Dec 28, 2025, RVTY reported annual earnings of $241.2M, with -10.8% growth.
RVTY past earnings growth
How has RVTY's earnings growth performed historically?
On RVTY's earnings call on Nov 3, 2026, Revvity (NYSE: RVTY) reported Q3 2026 earnings per share (EPS) of $0.56, up 40% year over year. Total RVTY earnings for the quarter were $62.30 million. In the same quarter last year, Revvity's earnings per share (EPS) was $0.40.
As of the last Revvity earnings report, Revvity is currently profitable. Revvity's net profit (also called net income) for the twelve months ending Oct 4, 2026 was $253.20 million, a 6.62% increase year over year.
What was RVTY's earnings growth in the past year?
As of Revvity's earnings date in Nov 3, 2026, Revvity's earnings has grown 13.07% year over year. This is 1.62 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 11.45%. RVTY earnings in the past year totalled $253.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.